Thiodigalactoside to help you breath
Could you imagine having known, you had just few breaths to live? Chemists at Galecto Biotech had successfully developed TDG-139 as a cure for IPF, scary lung disease. What is it and how it Idiopathic pulmonary fibrosis IPF is a type of chronic lung disease that gradually and irreversibly leads to decline in lung function. Scar tissue (fibrosis) is formed heavily in lungs, making it much harder for oxygen to pass to a bloodstream. This leads to a shortness of breath, dry coughing which rapidly escalates in scarring of ones’ lungs. Such affected people with IPF cannot provide oxygen for their bodies’ tissues and organs. They simply die of suffocation. No chance … Are thioglycosides the ultimate answer? Research in the field of galectins, which are proteins that bind to beta-galactoside sugars, revealed that galectines are largely involved in disease mechanisms. Galectin-3 is a member of galactosides binding family that initiates inflammatory and fibrotic activity....